Virtu Financial’s Phio Pharmaceuticals PHIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,214
Closed -$11K 2147
2025
Q4
$11K Buy
+10,214
New +$16.3K ﹤0.01% 1500
2025
Q3
Sell
-14,298
Closed -$34K 1935
2025
Q2
$34K Buy
+14,298
New +$28.9K ﹤0.01% 1189
2025
Q1
Sell
-40,910
Closed -$74K 1883
2024
Q4
$74K Buy
+40,910
New +$111K ﹤0.01% 1087
2024
Q2
Sell
-3,435
Closed -$21K 1755
2024
Q1
$21K Buy
3,435
+1,319
+62% +$9.09K ﹤0.01% 1159
2023
Q4
$14K Buy
+2,116
New +$21.7K ﹤0.01% 1373
2022
Q4
Sell
-180
Closed -$11K 2023
2022
Q3
$11K Buy
180
+38
+27% +$2.88K ﹤0.01% 1509
2022
Q2
$11K Sell
142
-253
-64% -$23.8K ﹤0.01% 1418
2022
Q1
$38K Sell
395
-65
-14% -$6.19K ﹤0.01% 1196
2021
Q4
$50K Buy
460
+39
+9% +$6.2K 0.01% 1343
2021
Q3
$92K Buy
421
+170
+68% +$35.5K 0.01% 1167
2021
Q2
$61K Buy
251
+107
+74% +$26.4K 0.01% 1303
2021
Q1
$42K Buy
+144
New +$47.9K ﹤0.01% 1453
2020
Q4
Sell
-333
Closed -$77K 1712
2020
Q3
$77K Buy
+333
New +$84.7K 0.01% 757
2019
Q4
$17K Buy
+16
New +$18.4K ﹤0.01% 1338
2019
Q2
Sell
-40
Closed -$107K 1756
2019
Q1
$107K Buy
+40
New +$89.7K 0.01% 1118
2018
Q3
Sell
-2
Closed -$23K 2026
2018
Q2
$23K Sell
2
-2
-50% -$29.6K ﹤0.01% 1847
2018
Q1
$67K Buy
+4
New +$92K ﹤0.01% 1657
2017
Q4
Hold
0
2249

Other funds holding PHIO

Virtu Financial's PHIO Position: Q1 2026 in Review

Virtu Financial sold out of Phio Pharmaceuticals (PHIO) in Q1 2026, closing a stake of 10,214 shares — an estimated $11K sold.

Virtu Financial first reported a position in PHIO in Q1 2018 and held it in 17 quarters. The position peaked at $107K in Q1 2019. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • Virtu Financial reported no remaining Phio Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 10,214 Phio Pharmaceuticals shares in Q1 2026, an estimated $11K.
  • Virtu Financial first reported a position in Phio Pharmaceuticals in Q1 2018 and held it in 17 quarters.
  • Virtu Financial's Phio Pharmaceuticals position peaked at $107K in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.